|
|
Starting with heart disease and then peripheral artery disease, TheraVitae has an unparalleled track record in developing adult stem cell therapies and bringing them to the market. TheraVitae’s researchers continue to work around the clock to ensure the best adult stem cell therapies for our patients in the near future.
In the pipeline are adult stem cell treatments for neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral sclerosis and stroke using neural-like cells. Other future targets are adult stem cell therapies for diabetes, renal failure, spinal injuries and multiple sclerosis.
Patients suffering from a wide variety of diseases will be able to be treated with cells manufactured from less than a pint of their own blood. This reinforces Hippocrates concept of letting the body heal itself.
|
Future Products
